These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28273738)

  • 1. Intravoxel incoherent motion MRI for monitoring the therapeutic response of hepatocellular carcinoma to sorafenib treatment in mouse xenograft tumor models.
    Lee Y; Lee SS; Cheong H; Lee CK; Kim N; Son WC; Hong SM
    Acta Radiol; 2017 Sep; 58(9):1045-1053. PubMed ID: 28273738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antiangiogenic and antiproliferative effects of sorafenib by sequential histology and intravoxel incoherent motion diffusion-weighted imaging in an orthotopic hepatocellular carcinoma xenograft model.
    Yang SH; Lin J; Lu F; Han ZH; Fu CX; Lv P; Liu H; Gao DM
    J Magn Reson Imaging; 2017 Jan; 45(1):270-280. PubMed ID: 27299302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
    Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
    World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MR diffusion-weighted imaging for monitoring the ultra-early treatment effect of sorafenib in human hepatocellular carcinoma xenografts.
    Chen X; Ma Z; Huang Y; He L; Liang C; Shi C; Zhang Z; Liang C; Liu Z
    J Magn Reson Imaging; 2017 Jul; 46(1):248-256. PubMed ID: 27783444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study.
    Shirota N; Saito K; Sugimoto K; Takara K; Moriyasu F; Tokuuye K
    Cancer Imaging; 2016 Jan; 16():1. PubMed ID: 26822946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes in apparent diffusion coefficient as an indicator of response to sorafenib in hepatocellular carcinoma.
    Zhao YL; Guo QQ; Yang GR; Wang QD
    J Zhejiang Univ Sci B; 2014 Aug; 15(8):713-9. PubMed ID: 25091989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.
    Lee S; Kim JH; Lee JH; Lee JH; Han JK
    Eur Radiol; 2018 Jan; 28(1):372-381. PubMed ID: 28752217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of tumor vascular normalization in colorectal cancer mouse mode induced by recombinant human endostatin by intravoxel incoherent motion diffusion-weighted magnetic resonance imaging].
    Zhu SB; Huang JL; Pan JH; Ding H; Zhao XX; Zhang D; Shi CZ; Pan YL
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):421-428. PubMed ID: 31216827
    [No Abstract]   [Full Text] [Related]  

  • 9. Early prediction of treatment response to sorafenib with elastosonography in a mice xenograft model of hepatocellular carcinoma: a proof-of-concept study.
    Salvatore V; Baron Toaldo M; Marinelli S; Milazzo M; Palamà C; Venerandi L; Cipone M; Bolondi L; Piscaglia F
    Ultraschall Med; 2013 Dec; 34(6):541-9. PubMed ID: 24132648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model.
    Guo R; Lu F; Lin J; Fu C; Liu M; Yang S
    Eur Radiol Exp; 2024 Mar; 8(1):43. PubMed ID: 38467904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors.
    Joo I; Lee JM; Han JK; Choi BI
    Radiology; 2014 Aug; 272(2):417-26. PubMed ID: 24697148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
    Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
    Kakite S; Dyvorne H; Besa C; Cooper N; Facciuto M; Donnerhack C; Taouli B
    J Magn Reson Imaging; 2015 Jan; 41(1):149-56. PubMed ID: 24415565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy response evaluation in a mouse model of gastric cancer using intravoxel incoherent motion diffusion-weighted MRI and histopathology.
    Cheng J; Wang Y; Zhang CF; Wang H; Wu WZ; Pan F; Hong N; Deng J
    World J Gastroenterol; 2017 Mar; 23(11):1990-2001. PubMed ID: 28373765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor perfusion-related parameter of diffusion-weighted magnetic resonance imaging: correlation with histological microvessel density.
    Lee HJ; Rha SY; Chung YE; Shim HS; Kim YJ; Hur J; Hong YJ; Choi BW
    Magn Reson Med; 2014 Apr; 71(4):1554-8. PubMed ID: 23798038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Histological Vessel Characteristics and Diffusion-Weighted Imaging Intravoxel Incoherent Motion-Derived Parameters in Pancreatic Ductal Adenocarcinomas and Pancreatic Neuroendocrine Tumors.
    Klau M; Mayer P; Bergmann F; Maier-Hein K; Hase J; Hackert T; Kauczor HU; Grenacher L; Stieltjes B
    Invest Radiol; 2015 Nov; 50(11):792-7. PubMed ID: 26186280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Ultrasmall Superparamagnetic Iron Oxide Enhanced Susceptibility Weighted Imaging and Mean Vessel Density Imaging to Monitor Antiangiogenic Effects of Sorafenib on Experimental Hepatocellular Carcinoma.
    Yang S; Lin J; Lu F; Han Z; Fu C; Gu H
    Contrast Media Mol Imaging; 2017; 2017():9265098. PubMed ID: 29097941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
    Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
    Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping.
    Liang J; Ma R; Chen H; Zhang D; Ye W; Shi C; Luo L
    AJR Am J Roentgenol; 2019 Apr; 212(4):717-726. PubMed ID: 30699010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.